News

Astex Therapeutics Ltd v AstraZeneca AB [2018] EWCA Civ 24446 November 2018The Court of Appeal upheld the decision of the trial judge in favour of AstraZeneca in relation to a contractual drug development dispute. The parties had engaged in a collaborative research program (the Program) aimed at identifying a drug suitable for inhibiting the BACE enzyme, thought to be involved in the development of Alzheimer’s disease. […]
Unwired Planet v Huawei [2018] EWCA Civ 234423 October 2018Andrew Lykiardopoulos QC, alongside James Segan of Blackstone Chambers, appeared for the Appellants, Huawei. Adrian Speck QC, Isabel Jamal and Tom Jones, alongside Sarah Ford QC of Brick Court Chambers, appeared for the Respondents, Unwired Planet. The appeal was from the decision of Birss J in which he had determined FRAND terms for a global […]
Parainen Pearl Shipping & Ors v Kristian Gerhard Jebsen Skipsrederi [2018] EWHC 2628 (Pat)11 October 2018Tom Moody-Stuart QC and Lindsay Lane appeared for the Claimants in their claim for a declaration of non-infringement of a patent for a pneumatic cement discharge system. James Abrahams QC, alongside Kathryn Pickard of 11 South Square, appeared for the Defendants. The Claimants own a vessel incorporating a pneumatic cement discharge system in accordance with […]
Conversant Wireless Licensing SARL v Huawei Technologies and Ors [2018] EWHC 808 (Pat)23 May 2018Adrian Speck QC, Isabel Jamal and Thomas Jones appeared for the Claimant, Conversant, in the Defendants’ challenge to the jurisdiction of the English court. Conversant’s claim is for patent infringement by the Defendants, and seeks the determination of a FRAND licence as part of its claimed relief. The Defendants argued that the English court had […]
Opinion of the Advocate General in Teva v Gilead SPC case25 April 2018On 25 April 2018, Advocate General Wathelet gave his opinion in Teva and others v Gilead Case C-121/17, referred to the CJEU by Arnold J last year. This important case, in which the CJEU sat, unusually, in a Grand Chamber, considered again the interpretation of Article 3(a) of the Supplementary Protection Certificate Regulation and the […]